blue pharmacies - An Overview
No clinically major variations in the pharmacokinetics of midazolam (CYP3A4 substrate) or its metabolite one-hydroxymidazolam were being noticed when used concomitantly with solitary or multiple doses of lumateperone in clients with schizophrenia.Concomitant usage of CAPLYTA with reasonable or strong CYP3A4 inhibitors increases lumateperone publici